World Council of Churches

A worldwide fellowship of churches seeking unity, a common witness and Christian service

You are here: Home / What we do / Ecumenical Advocacy Alliance / Live the Promise: HIV Campaign

Live the Promise: HIV Campaign

The Ecumenical Advocacy Alliance (now an ecumenical initiative of the WCC) has campaigned on HIV and AIDS for over 14 years, advocating for access to treatment, eradication of stigma and discrimination, elimination of root causes of vulnerability to HIV transmission, and fulfillment of commitments by governments, intergovernmental organizations, religious leaders, faith organizations and individuals. Much progress has been made during this period to extend access to treatment, reduce transmission, improve education, and coordinate resources. But AIDS is not over – and political will to sustain progress and scale up effective responses that could eliminate HIV in the next generation seems to be faltering.

The Ecumenical Advocacy Alliance (EAA) has campaigned on HIV and AIDS for over 14 years, advocating for access to treatment, eradication of stigma and discrimination, elimination of root causes of vulnerability to HIV transmission, and fulfillment of commitments by governments, intergovernmental organizations, religious leaders, faith organizations and individuals. Much progress has been made during this period to extend access to treatment, reduce transmission, improve education, and coordinate resources. But AIDS is not over – and political will to sustain progress and scale up effective responses that could eliminate HIV in the next generation seems to be faltering.

Join us in working for a future without AIDS! Speak out and take action nationally and international for a strong Political Declaration at the United Nations High-Level Meeting on AIDS.

The Ecumenical Advocacy Alliance has earned a high level of recognition and respect in international policy spaces and multilateral organizations, including the post-2015 civil society working group, Free Space Process, and the UNAIDS Programme Coordinating Board.

In its 2013 General Assembly, EAA organizations voted to “continue to work together on HIV and AIDS, seeking to eliminate stigma and make a significant contribution to the vision of “getting to zero”: zero new infections, zero discrimination and zero AIDS-related deaths.” This campaign runs from 2014-2017.

Examples of recent major campaign initiatives led by the EAA:

  • Advocacy and dialogue with pharmaceutical companies to ensure affordable and accessible treatment, particularly for children. The EAA has specifically promoted comprehensive agreements between companies and the Medicines Patent Pool.
  • The Summit of High Level Religious Leaders on HIV held in the Netherlands in March 2010, and the Personal Commitment developed and signed by senior religious leaders from a spectrum of world religions (www.hivcommitment.net);
  • Development and implementation of the Framework for Dialogue between Religious Leaders and People Living with HIV at the national level, in cooperation with GNP+, INERELA+ and UNAIDS. Dialogues have been held, are in process, in Malawi, Myanmar, Ethiopia, Uganda, Kenya and Nigeria;
  • A multi-sectoral consultation process on Human Rights, Theology and HIV leading to a publication in 2016 on Christian Perspective on HIV, AIDS and Human Rights;
  • EAA’s ecumenical and interfaith mobilization and coordination at all International AIDS Conferences since 2006, including ecumenical and interfaith pre-conferences.

Hosted by the WCC since 2015, the EAA continues to:

  • Advocate for access to treatment for all in need
  • Maintain pressure on governments, multisectoral organizations, private sector and leaders of all levels to strengthen the global efforts on HIV, ensuring that progress is not lost. This includes preparations for the next International AIDS Conference and work on the post-2015 sustainable development goals.
  • Promote and facilitate national dialogue and action on human rights and HIV through the Framework for Dialogue, guided by an international steering committee involving GNP+, INERELA+, UNAIDS and the EAA.

Related Events

Interfaith Pre-Conference at AIDS 2016

Interfaith Pre-Conference at AIDS 2016

16 - 17 July 2016 Durban, South Africa

The International AIDS Conference (18-22 July) provides extensive opportunities for sharing and networking across all levels of care and response to the epidemic. It draws tens of thousands of people every two years. The WCC-Ecumenical Advocacy Alliance is coordinating an Interfaith Pre-Conference to bring faith-based participants together to share good practices, networking, and discussion of the faith-based response to current challenges in responding to HIV.

Related News

Registration opens for July interfaith pre-conference on AIDS

Registration opens for July interfaith pre-conference on AIDS

The World Council of Churches Ecumenical Advocacy Alliance is taking registrations and workshop proposals for “Faith on the Fast Track,” an interfaith pre-conference scheduled for 16-17 July in Durban, South Africa.

United Nations High Level Meeting on AIDS

A UN High-Level Meeting on AIDS (HLM) will be held 8-10 June at the United Nations Headquarters in New York. Through the HLM, the international community can demonstrate commitment to accelerating the HIV response with the goal of ending the AIDS epidemic. Concerted advocacy by people of faith is a vital part of efforts to encourage governments to develop and adopt a Political Declaration with new and bold commitments – matched by funding commitments – to scale up prevention, treatment, care and support, eliminate stigma and discrimination, uphold human rights, and ensure the engagement of communities most affected.

Medicines Patent Pool, ViiV Healthcare expand licensing agreement

Medicines Patent Pool, ViiV Healthcare expand licensing agreement

The World Council of Churches – Ecumenical Advocacy Alliance (WCC-EAA) welcomes the 25 April announcement by the Medicines Patent Pool (MPP) and ViiV Healthcare of the geographic extension of their licensing agreement for dolutegravir (DTG) to cover all remaining lower middle-income countries (LMICs). The amendment to the 2014 licence specifically allows generic medicine distribution in four countries with patents – Armenia, Moldova, Morocco and Ukraine – that were not covered in the initial agreement. Dolutegravir is a promising new treatment that was included in the latest WHO guidelines as first- and third-line treatment.